scholarly journals Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies

Oncotarget ◽  
2017 ◽  
Vol 8 (27) ◽  
pp. 44881-44892 ◽  
Author(s):  
Zhi-Feng Miao ◽  
Hao Xu ◽  
Ying-Ying Xu ◽  
Zhen-Ning Wang ◽  
Ting-Ting Zhao ◽  
...  
Oncotarget ◽  
2017 ◽  
Vol 8 (33) ◽  
pp. 55622-55631 ◽  
Author(s):  
Xue-Liang Zhou ◽  
Wen-Hua Xue ◽  
Xian-Fei Ding ◽  
Li-Feng Li ◽  
Meng-Meng Dou ◽  
...  

2011 ◽  
Vol 120 (04) ◽  
pp. 217-223 ◽  
Author(s):  
T. Tian ◽  
L. Zhang ◽  
X. Ma ◽  
J. Zhou ◽  
J. Shen

AbstractEpidemiologic studies have examined the possible associations between diabetes mellitus (DM) and gastric cancer (GC), but the results are inconclusive. We conducted a meta-analysis to assess the evidence regarding the associations between diabetes and incidences of, or mortality from, gastric cancer.PubMed, Embase and Web of Science were searched up to Oct 20, 2011. We identified studies that included effects estimates with 95% confidence intervals (CIs) of the associations between GC and diabetes. Summary RRs for the GC incidence and mortality were calculated using random-effects model; subgroup analyses were also performed. Heterogeneity among studies was examined using Q and I2 statistics.A total of 7 case-control and 18 cohort studies met the inclusion criteria. The summary RR showed a slightly statistical link between history of DM and GC incidence (RR=1.11, 95% CI: 1.00–1.24, p=0.045, I2=79.5%). In the subgroup analyses, a positive association was noted among the studies conducted in Asia (summary RR=1.19, 95% CI: 1.07–1.32, I2=29.8%). Additionally, slight associations between DM and GC were observed by pooling the data of type 2 DM, cohort studies and the studies controlling more confounders, respectively. Furthermore, mortality from GC with diabetes was increased compared with individuals without diabetes (summary RR=1.29, 95% CI: 1.04–1.59). No publication bias was found.Individuals with diabetes have an increased risk of developing gastric cancer, and are positively associated with gastric cancer mortality. Large better-designed cohort studies are needed to verify this conclusion.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Eric Lontchi-Yimagou ◽  
Charly Feutseu ◽  
Sebastien Kenmoe ◽  
Alexandra Lindsey Djomkam Zune ◽  
Solange Fai Kinyuy Ekali ◽  
...  

AbstractA significant number of studies invoked diabetes as a risk factor for virus infections, but the issue remains controversial. We aimed to examine whether non-autoimmune diabetes mellitus enhances the risk of virus infections compared with the risk in healthy individuals without non-autoimmune diabetes mellitus. In this systematic review and meta-analysis, we assessed case-control and cohort studies on the association between non-autoimmune diabetes and viruses. We searched PubMed, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and Web of Science with no language restriction, to identify articles published until February 15, 2021. The main outcome assessment was the risk of virus infection in individuals with non-autoimmune diabetes. We used a random-effects model to pool individual studies and assessed heterogeneity (I2) using the χ2 test on Cochrane’s Q statistic. This study is registered with PROSPERO, number CRD42019134142. Out of 3136 articles identified, we included 68 articles (90 studies, as the number of virus and or diabetes phenotype varied between included articles). The summary OR between non-autoimmune diabetes and virus infections risk were, 10.8(95% CI: 10.3–11.4; 1-study) for SARS-CoV-2; 3.6(95%CI: 2.7–4.9, I2 = 91.7%; 43-studies) for HCV; 2.7(95% CI: 1.3–5.4, I2 = 89.9%, 8-studies;) for HHV8; 2.1(95% CI: 1.7–2.5; 1-study) for H1N1 virus; 1.6(95% CI: 1.2–2.13, I2 = 98.3%, 27-studies) for HBV; 1.5(95% CI: 1.1–2.0; 1-study) for HSV1; 3.5(95% CI: 0.6–18.3 , I2 = 83.9%, 5-studies) for CMV; 2.9(95% CI: 1–8.7, 1-study) for TTV; 2.6(95% CI: 0.7–9.1, 1-study) for Parvovirus B19; 0.7(95% CI: 0.3–1.5 , 1-study) for coxsackie B virus; and 0.2(95% CI: 0–6.2; 1-study) for HGV. Our findings suggest that, non-autoimmune diabetes is associated with increased susceptibility to viruses especially SARS-CoV-2, HCV, HHV8, H1N1 virus, HBV and HSV1. Thus, these viruses deserve more attention from diabetes health-care providers, researchers, policy makers, and stakeholders for improved detection, overall proper management, and efficient control of viruses in people with non-autoimmune diabetes.


Tumor Biology ◽  
2014 ◽  
Vol 35 (9) ◽  
pp. 8525-8532 ◽  
Author(s):  
Jizhun Zhang ◽  
Yangbing Zhou ◽  
Kewei Jiang ◽  
Zhanlong Shen ◽  
Yingjiang Ye ◽  
...  

2011 ◽  
Vol 47 (13) ◽  
pp. 1928-1937 ◽  
Author(s):  
Qiwen Ben ◽  
Maojin Xu ◽  
Xiaoyan Ning ◽  
Jun Liu ◽  
Shangyou Hong ◽  
...  

2009 ◽  
Vol 45 (16) ◽  
pp. 2867-2873 ◽  
Author(s):  
Ping Yang ◽  
Yong Zhou ◽  
Bo Chen ◽  
Hong-Wei Wan ◽  
Gui-Qing Jia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document